Preventing Alzheimer's in African-Americans by strengthening the brain

by Rutgers UniversityZumba class at New Hope Baptist Church in Newark, N.J. Credit: Dr. Mark GluckA major effort is underway to reduce the risk of Alzheimer's disease and other forms of demen

Updated on: February 28,2024

Preventing Alzheimer's in African-Americans by strengthening the brain

by Rutgers UniversityZumba class at New Hope Baptist Church in Newark, N.J. Credit: Dr. Mark GluckA major effort is underway to reduce the risk of Alzheimer's disease and other forms of demen

Updated on:February 28,2024

Untangling tau—researchers find a 'druggable target' for treating Alzheimer's disease

by University of California - San DiegoA micrograph by Thomas Deerinck of the National Center for Microscopy and Imaging Research at UC San Diego School of Medicine depicts tangles of tau protein

Updated on: July 01,2024

Untangling tau—researchers find a 'druggable target' for treating Alzheimer's disease

by University of California - San DiegoA micrograph by Thomas Deerinck of the National Center for Microscopy and Imaging Research at UC San Diego School of Medicine depicts tangles of tau protein

Updated on:July 01,2024

The cloud facilitates independent living for the elderly

by CORDISCredit: Maria Fernanda Cabrera UmpiérrezAging can be accompanied by cognitive deterioration that may affect life quality and possibly safety. EU research has developed a range of ICT sol

Updated on: March 09,2024

The cloud facilitates independent living for the elderly

by CORDISCredit: Maria Fernanda Cabrera UmpiérrezAging can be accompanied by cognitive deterioration that may affect life quality and possibly safety. EU research has developed a range of ICT sol

Updated on:March 09,2024

The search for early markers of Alzheimer's Disease

by Ríona Mc Ardle,Public Library of ScienceRegional MRI predictors of MCI-to-dementia progression. Figure courtesy Korolev et al. via PLOS One.This eloquent quote by V.S. Ramachandran expresses

Updated on: February 28,2024

The search for early markers of Alzheimer's Disease

by Ríona Mc Ardle,Public Library of ScienceRegional MRI predictors of MCI-to-dementia progression. Figure courtesy Korolev et al. via PLOS One.This eloquent quote by V.S. Ramachandran expresses

Updated on:February 28,2024

Flotillin is a novel diagnostic blood marker of Alzheimer's disease

by Nagoya City UniversityFlotillin in serum collected from patients with AD and non-AD cases was examined by western blot analysis. Intensity of flotillin bands was quantified using Image J. A, The re

Updated on: March 30,2024

Flotillin is a novel diagnostic blood marker of Alzheimer's disease

by Nagoya City UniversityFlotillin in serum collected from patients with AD and non-AD cases was examined by western blot analysis. Intensity of flotillin bands was quantified using Image J. A, The re

Updated on:March 30,2024

Possible pathway to new therapy for Alzheimer's disease

by Boston University School of MedicineResearchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of bet

Updated on: March 07,2024

Possible pathway to new therapy for Alzheimer's disease

by Boston University School of MedicineResearchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of bet

Updated on:March 07,2024

New review suggests evaluating Tibetan medicinal herb as potential treatment for mild cognitive impairment

by Stephanie Baum , Medical XpressCredit:Frontiers in Pharmacology(2024). DOI: 10.3389/fphar.2024.1484040Within Tibetan medicine, the medicinal herb Terminalia chebula (T. chebula) is well

Updated on: November 07,2024

New review suggests evaluating Tibetan medicinal herb as potential treatment for mild cognitive impairment

by Stephanie Baum , Medical XpressCredit:Frontiers in Pharmacology(2024). DOI: 10.3389/fphar.2024.1484040Within Tibetan medicine, the medicinal herb Terminalia chebula (T. chebula) is well

Updated on:November 07,2024

Midbrain dopamine neurons can retain short-term memories, study shows

byRIKENIdentifying midbrain dopaminergic and GABAergic neurons. Credit:(2024). DOI: 10.7554/eLife.89743.2Dopamine neurons in the midbrain are involved in storing short-term memories—a func

Updated on: July 05,2024

Midbrain dopamine neurons can retain short-term memories, study shows

byRIKENIdentifying midbrain dopaminergic and GABAergic neurons. Credit:(2024). DOI: 10.7554/eLife.89743.2Dopamine neurons in the midbrain are involved in storing short-term memories—a func

Updated on:July 05,2024

Study investigates how effective multiple sclerosis medications are across racial and ethnic groups

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainFor people with relapsing-remitting multiple sclerosis (MS), a new study has found that the drug ofatumumab is more effective tha

Updated on: July 31,2024

Study investigates how effective multiple sclerosis medications are across racial and ethnic groups

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainFor people with relapsing-remitting multiple sclerosis (MS), a new study has found that the drug ofatumumab is more effective tha

Updated on:July 31,2024

Benzodiazepines increase mortality in persons with Alzheimer's disease

by University of Eastern FinlandBenzodiazepine and related drug use is associated with a 40 percent increase in mortality among persons with Alzheimer's disease, according to a new study from

Updated on: March 07,2024

Benzodiazepines increase mortality in persons with Alzheimer's disease

by University of Eastern FinlandBenzodiazepine and related drug use is associated with a 40 percent increase in mortality among persons with Alzheimer's disease, according to a new study from

Updated on:March 07,2024

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on: March 30,2024

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on:March 30,2024

Brain takes a beating as arteries age

by Umea UniversityCredit: CC0 Public DomainResearchers in Umeå, Sweden, have presented a model that explains why memory deteriorates as the body ages. With age, the brain receives an increased lo

Updated on: May 20,2024

Brain takes a beating as arteries age

by Umea UniversityCredit: CC0 Public DomainResearchers in Umeå, Sweden, have presented a model that explains why memory deteriorates as the body ages. With age, the brain receives an increased lo

Updated on:May 20,2024